❭ Action plans and policy papers ❭

Action plans and policy papers

Protocol: An anonymized GWAS to urgently query host genetic predisposition to severe COVID-19 (SARS-CoV-2 infection) lung disease (open as PDF)
Criteria for excellent research in KIT – report from work group (in Norwegian only) (open as PDF)
User involvement: possible models in KIT. Report from work group (in Norwegian only) (open as PDF)
Handlingsplan for forskning i KIT for 2021 (open as PDF)
Handlingsplan for forskning i KIT for 2022 (open as PDF)
Handlingsplan for forskning i KIT for 2023 (open as PDF)
 
Scroll to top

Home Div. of Surgery, Inflammatory Diseases and Transplantation

  • Research Institute of Internal Medicine
  • Research Management and the Research Committee
  • Action plans and policy papers
  • Strategisk protokollutvalg KIT
  • Annual reports
  • Research staff
  • Thematic areas

Recent publications

Huse C, Gregersen I, Holme FA, Ueland T, Skjelland M, Aamodt AH, Dahl TB, Aukrust P, Halvorsen B (2026)
Role of Interleukin-6 in Atherothrombosis and Myocardial Infarction
Curr Atheroscler Rep, 28 (1), 13
DOI 10.1007/s11883-025-01387-8, PubMed 41543641

Valestrand L, Nordhus KS, Claudel T, Øgaard J, Frank A, Amundsen-Isaksen E, Fuchs C, Berntsen NL, Chung BK, Jiang X, Trauner M, Melum E (2026)
Natural Killer T cells promote cholestatic liver disease independent of antigen presentation by cholangiocytes
Hepatol Commun, 10 (2)
DOI 10.1097/HC9.0000000000000862, PubMed 41543487

Ibsen JH, Kongsgaard A, Sovershaev M, Lund SR, Paulsen V, Darre-Næss O, Garborg K, Tønnesen C, Aabakken L, Risnes LF, Lundin KEA (2026)
Serology-based diagnosis of coeliac disease in secondary care: a single-centre study in Norway
Scand J Gastroenterol, 1-11 (in press)
DOI 10.1080/00365521.2026.2615407, PubMed 41543110

Rodriguez-Jimenez FJ, Artero-Castro A, Studenovska H, Selles F, Arteaga Claramunt AM, Brymova A, Jendelova P, Motlik J, Petrovski G, Lytvynchuk L, Ardan T, Tichotová L, Drutovič S, Sharma R, Lukovic D, Bharti K, Erceg S (2025)
Corrigendum to 'Restored phagocytic ability of RPE patches derived from gene-corrected retinitis pigmentosa-hiPSCs on a biodegradable scaffold via clinical-grade protocol: Implications for autologous therapy' [Genes Dis (12) (2025) 101609]
Genes Dis, 13 (2), 101912
DOI 10.1016/j.gendis.2025.101912, PubMed 41542338

More publications